Sihuan Pharmaceutical Holdings Group Company Description

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China, the United States, and internationally.

It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.

The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions.

It also provides drugs for cardio-cerebral vascular, digestive system, anti-infective, metabolism, respiratory, neurology, oncology, diabetes, and other indications, as well as modern Chinese medicine and industrial hemp products.

In addition, the company offers general hospital services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.

Sihuan Pharmaceutical Holdings Group Ltd.

Country	Bermuda
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,843
CEO	Weicheng Guo

Contact Details

Address: Office Tower, Convention Plaza Wan Chai Hong Kong
Phone	852 3628 3911
Website	sihuanpharm.com

Stock Details

Ticker Symbol	0460
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	BMG8162K1137
SIC Code	2834

Key Executives

Name	Position
Guili Miao	Deputy Chief Executive Officer, Chief Investment Officer, Chief Financial Officer and Executive Director
Dr. Weicheng Guo Ph.D.	Deputy Chairman and Chief Executive Officer
Dr. Fengsheng Che	Co-Founder and Executive Chairman
Dr. Jionglong Zhang Ph.D.	Executive Director
Yanling Chen	Joint Company Secretary and Executive Director
Kin Wai Li	Joint Company Secretary
Xianhui Meng	Deputy General Manager